Stocks · News reference
Filed: 2026-09-08 AccNo: 0001493152-26-041725 Size: 272 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-09-09 AccNo: 0001493152-26-041918 Size: 302 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Aspire Biopharma Holdings (ASBP) announced it will present live at the Life Sciences Investor Forum on June 25th, 2026. The company highlighted its multiple prescription applications in cardiovascular and other therapeutic areas, its lead drug candidate high-dose aspirin product, and the commercial launch of BUZZ BOMB caffeine product. Aspire also announced a proposed acquisition of Dura Driver Control Systems, expected to close in Q3 2026.